For the Inventor, By the Inventor

Enter assignee name

San Ramon, CA, United States of America

Bioventrix, Inc.

Calculating rank

USPTO Granted Patents = 57

EPO Patents = 15

Trademarks = 4

Forward Citations = 1,023

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Lon S Annest (55 out of 64 patents)

Kevin H Van Bladel (25 out of 49 patents)

Sing-Fatt Chin (19 out of 26 patents)

4. Arthur A Bertolero (17 out of 70 patents)

5. Rovil Arcia (13 out of 13 patents)

6. David K Swanson (12 out of 331 patents)

7. William E Butler (11 out of 37 patents)

8. Ernie Heflin (10 out of 10 patents)

9. John Bower (10 out of 11 patents)

10. Ernest Heflin (10 out of 14 patents)

11. Murray Sheldon (8 out of 8 patents)

12. Andrew Wechsler (8 out of 8 patents)

13. John Stiggelbout (8 out of 22 patents)

14. Claudio Argento (7 out of 90 patents)

15. Meir H Moshe (6 out of 15 patents)

Core Competencies:

Heart Anchor

Ventricular Reconstruction

Cardiac Tissue Penetrating

Tissue Protecting Devices

Percutaneous Access

Lesion Excluding Implants

Cardiac Implant Delivery

Dysfunctional Cardiac Tissue

Remote Hemostasis

Cardiac Tissue Anchoring

Trans-catheter Structures

Pressure Determining Devices

57 patents: Sort by Forward Citations

1. 12582524 - Heart anchor positioning devices, methods, and systems for treatment of congestive heart failure and other conditions (2026-03-24),

2. 12533235 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions (2026-01-27),

3. 11903834 - Heart anchor positioning devices, methods, and systems for treatment of congestive heart failure and other conditions (2024-02-20),

4. 11793643 - Method and apparatus for closing off a portion of a heart ventricle (2023-10-24),

5. 11744615 - Pericardial inflation catheter and systems and methods employing same (2023-09-05),

6. 11559212 - Cardiac tissue penetrating devices, methods, and systems for treatment of congestive heart failure and other conditions (2023-01-24),

7. 11540822 - Cardiac tissue anchoring devices, methods, and systems for treatment of congestive heart failure and other conditions (2023-01-03),

8. 11529234 - Tissue protecting devices for treatment of congestive heart failure and other conditions (2022-12-20),

9. 11478353 - Percutaneous arterial access to position trans-myocardial implant devices and methods (2022-10-25),

10. 11419723 - Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states (2022-08-23),

11. 11399942 - Treating dysfunctional cardiac tissue (2022-08-02),

12. 11331190 - Steerable lesion excluding heart implants for congestive heart failure (2022-05-17),

13. 11273040 - Method and device for percutaneous left ventricular reconstruction (2022-03-15),

14. 11259929 - Method and device for treating dysfunctional cardiac tissue (2022-03-01),

15. 11185414 - Systems and methods for deploying a cardiac anchor (2021-11-30),

Company Overview

Bioventrix, Inc., based in San Ramon, California, specializes in innovative cardiac devices aimed at addressing heart dysfunction. The company focuses on advanced technologies such as heart anchors and ventricular reconstruction, which are designed to improve the treatment of dysfunctional cardiac tissue. Their expertise extends to the development of tissue penetrating and protecting devices, as well as percutaneous access solutions and lesion excluding implants, enhancing the delivery of cardiac implants and overall patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

57 Patents

#7 in San Ramon, CA

#1,467 in California

#6,254 in US

#12,581 in the World

San Ramon, CA, United States of America

Bioventrix, Inc.

Forward Citations = 1,023

23 inventors:

Lon S Annest (55 out of 64 patents)

Kevin H Van Bladel (25 out of 49 patents)

Sing-Fatt Chin (19 out of 26 patents)

4. Arthur A Bertolero (17 out of 70 patents)

5. Rovil Arcia (13 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioventrix, Inc.. Retrieved from https://idiyas.com/company/bioventrix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…